CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

Clinical trial NCT00174616 · COMPLETED

Trial details

NCT number: NCT00174616
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Neoplasms

Start date: 2003-07-01
Primary completion: 2007-11-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.